This Article  • Excerpt  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Arch Dermatol. 1990;126(10):1274.

References
Article references have been provided for searching and linking. Additional reference information may be available in the article PDF.

1. CDC. Eosinophilia-myalgia syndrome—New Mexico. MMWR 1989;38:765-7. PUBMED 2. CDC. Eosinophilia-myalgia syndrome and L-tryptophan-containing products—New Mexico, Minnesota, Oregon, and New York, 1989. MMWR 1989;38:785-8. PUBMED 3. Slutsker L, Hoesly FC, Miller L, Williams P, Watson JC, Fleming DW. Eosinophilia-myalgia syndrome associated with exposure to tryptophan from a single manufacturer. JAMA 1990;264: 213-7. FREE FULL TEXT 4. Belongia EA, Hedberg CW, White KE, MacDonald KL, Osterholm MT. Epidemiology of eosinophilia-myalgia syndrome in Minnesota. Presented at the 39th Annual Epidemic Intelligence Service Conference, CDC, Atlanta, April 25, 1990. 5. Belongia EA, Hedberg CW, Gleich GJ, et al. An investigation of the cause of the eosinophiliamyalgia syndrome associated with tryptophan use. N Engl J Med 1990;323:357-65. ABSTRACT 6. Needham L, Page S. Chemical analysis of LTCPS and related samples. Conference on Eosinophilia-Myalgia Syndrome, Los Alamos National Laboratory, Los Alamos, New Mexico, June 12, 1990. 7. Buckholtz NS. Neurobiology of tetrahydrobeta-carbolines. Life Sci 1980;27:893-903. PUBMED

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?